Notice: This company has been marked as potentially delisted and may not be actively trading. Roivant Sciences (ROIVW) News Today Add Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Optimistic Outlook on Roivant Sciences Despite Namilumab SetbackDecember 6, 2024 | markets.businessinsider.comSeveral Positive Developments Lifted Roivant (ROIV) in Q3December 6, 2024 | msn.comThe Analyst Landscape: 5 Takes On Roivant SciencesNovember 14, 2024 | benzinga.comRoivant Sciences Reports Q2 2024 Financial ResultsNovember 14, 2024 | markets.businessinsider.comRoivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call TranscriptNovember 14, 2024 | msn.comRoivant Sciences Ltd (ROIV) Q2 2024 Earnings Call Highlights: Strong Cash Position and ...November 13, 2024 | finance.yahoo.comRoivant Sciences Ltd. (ROIV): Among the Most Promising Mid-Cap Stocks According to Hedge FundsOctober 14, 2024 | msn.comIs Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $20?October 8, 2024 | msn.comIs Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $50 To Buy?September 30, 2024 | finance.yahoo.comROIV Roivant Sciences Ltd.September 28, 2024 | seekingalpha.comQVT Financial LP Adjusts Stake in Roivant Sciences LtdSeptember 27, 2024 | finance.yahoo.comIs Roivant Sciences Ltd. (ROIV) the Best Guru Stock To Buy Now?September 25, 2024 | msn.comRoivant Sciences maintains buy rating by H.C. WainwrightSeptember 21, 2024 | uk.investing.comAnalysts Offer Insights on Healthcare Companies: Progyny (PGNY) and Roivant Sciences (ROIV)September 19, 2024 | markets.businessinsider.comPromising Outlook for Roivant Sciences’ Mosliciguat in Treating PH-ILD: An Analytical PerspectiveSeptember 13, 2024 | markets.businessinsider.comMosliciguat for PH-ILD: A Cautious Hold Rating Amidst Promising Phase 1 ResultsSeptember 11, 2024 | markets.businessinsider.comRoivant Provides Update on Graves’ Disease Development ProgramSeptember 9, 2024 | markets.businessinsider.comRoivant Sciences Ltd (87S.DU)August 23, 2024 | sg.finance.yahoo.comShareholders In Roivant Sciences (NASDAQ:ROIV) Should Look Beyond Earnings For The Full StoryAugust 22, 2024 | finance.yahoo.comBuy Rating Affirmed on Roivant Sciences Ahead of Revealing High-Potential Phase 2 Asset and Promising Pipeline MilestonesAugust 14, 2024 | markets.businessinsider.comBalancing Act: Hold Recommendation Amidst Roivant Sciences’ Sales Shortfalls and Promising Pipeline PotentialAugust 9, 2024 | markets.businessinsider.comRoivant Sciences Ltd. (ROIV) Q1 2025 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.com3 Best Stocks to Buy Now, 7/19/2024, According to Top AnalystsJuly 20, 2024 | msn.comPiper Sandler Keeps Their Buy Rating on Roivant Sciences (ROIV)July 19, 2024 | markets.businessinsider.comInstitutional Investors are Betting on Roivant Sciences (NASDAQ:ROIV)May 27, 2024 | msn.comInstitutional investors are Roivant Sciences Ltd.'s (NASDAQ:ROIV) biggest bettors and were rewarded after last week's US$290m market cap gainMay 5, 2024 | finance.yahoo.comBuy Rating Justified by Roivant Sciences’ Strategic Positioning and Promising Drug PipelineMay 2, 2024 | markets.businessinsider.comCritical Insights From Roivant Sciences Analyst Ratings: What You Need To KnowApril 22, 2024 | markets.businessinsider.comBuy Rating Affirmed for Roivant Sciences Amid Brepocitinib Success and Strategic Share Repurchase ProgramApril 3, 2024 | markets.businessinsider.comStocks Fall as Bond Yields Climb on Strong US Economic NewsApril 2, 2024 | msn.comRoivant Reports Positive NEPTUNE Study Results; Approves Share Repurchase For Up To $1.5 BlnApril 2, 2024 | markets.businessinsider.comVivek Ramaswamy-Founded Roivant's Anti-Inflammatory Drug Aces Mid-Stage StudyApril 2, 2024 | msn.comTech Stocks Pressured by NvidiaMarch 28, 2024 | theglobeandmail.comStocks Push Higher as T-note Yields SlipMarch 28, 2024 | msn.comRoche to Buy Telavant for $7.1 BillionMarch 12, 2024 | msn.comTrading was temporarily halted for "ROIVW" at 04:09 PM with a stated reason of "News pending."September 1, 2023 | marketbeat.comRoivant Sciences Ltd.'s (NASDAQ:ROIV) hedge funds investors lost 4.2% last week but have benefitted from longer-term gainsApril 28, 2023 | finance.yahoo.comWhy Did Pfizer Offload This Potential Mega-Blockbuster Drug?April 23, 2023 | msn.comWhy Shares of Roivant Sciences Jumped This WeekApril 20, 2023 | msn.com Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIVW and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol ROIVW Media Mentions By Week ROIVW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROIVW News Sentiment▼0.000.58▲Average News Sentiment ROIVW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROIVW Articles This Week▼00▲ROIVW Articles Average Week Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIVW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ROIVW) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
